UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY16 earnings guidance on Tuesday morning. The company provided EPS guidance of ~$8.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.92.

UnitedHealth Group Inc. (NYSE:UNH) opened at 134.13 on Tuesday. UnitedHealth Group Inc. has a 12-month low of $107.51 and a 12-month high of $144.48. The company has a market cap of $127.74 billion, a P/E ratio of 20.99 and a beta of 0.57. The firm’s 50-day moving average price is $136.95 and its 200-day moving average price is $136.65.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The business earned $46.30 billion during the quarter, compared to analyst estimates of $46.06 billion. During the same period last year, the company earned $1.77 earnings per share. UnitedHealth Group’s quarterly revenue was up 11.6% compared to the same quarter last year. Analysts expect that UnitedHealth Group Inc. will post $7.90 EPS for the current year.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were issued a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.86%. UnitedHealth Group’s dividend payout ratio is 39.12%.

Several brokerages recently issued reports on UNH. Credit Suisse Group AG reiterated a buy rating and set a $155.00 price objective (up from $148.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Vetr upgraded UnitedHealth Group from a buy rating to a buy rating in a report on Friday, October 7th. Zacks Investment Research lowered UnitedHealth Group from a hold rating to a sell rating in a report on Monday, July 18th. Jefferies Group restated a buy rating and set a $163.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 4th. Finally, Leerink Swann restated a buy rating on shares of UnitedHealth Group in a report on Monday, June 27th. One investment analyst has rated the stock with a hold rating, twenty-five have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus target price of $155.35.

In other news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.65% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Van Hulzen Asset Management LLC purchased a new position in UnitedHealth Group during the second quarter worth about $104,000. Eubel Brady & Suttman Asset Management Inc. purchased a new position in UnitedHealth Group during the second quarter worth about $209,000. Bellwether Investment Group LLC purchased a new position in UnitedHealth Group during the second quarter worth about $220,000. Ancora Advisors LLC purchased a new position in UnitedHealth Group during the second quarter worth about $238,000. Finally, MCF Advisors LLC boosted its position in UnitedHealth Group by 79.6% in the second quarter. MCF Advisors LLC now owns 1,721 shares of the healthcare conglomerate’s stock worth $243,000 after buying an additional 763 shares during the period. Institutional investors own 85.80% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.